APOA1 and Parkinson disease: Lawton et al. found that a range of differences between apolipoprotein A1 and C‐reactive protein levels in the subtypes of PD, and apolipoprotein A1 reduced and higher C‐reactive protein levels in severe motor disease phenotypes, poor mental health, and sleep subtypes.